nohealthproblemsnews.com
Home »
(Reuters Health) – Despite adjustments to the U.S. Preventive Services Task Force lung cancer screening criteria, disparities in eligibility between […] Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology. […] The US Food and Drug Administration (FDA) has granted an accelerated approval to mobocertinib (Exkivity, Takeda) for the treatment of […] Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell […] Lung cancer is a major global cause of mortality, reportedly accounting for 1.7 million deaths each year. The most common […] BRUSSELS (Reuters) – The European Commission said on Thursday it was suing Slovakia for years-long breaches of legal limits on […] A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […] Lung cancer is one of the most common and serious types of cancer. Around 47,000 people are diagnosed with the […] Lung cancer is one of the most serious types of cancer to be diagnosed, as it’s usually difficult to spot […] Hepatoblastoma is a rare form of liver cancer affecting just a few individuals per million. However, it is the leading […]
Revised Guidelines Did Not Reduce Disparities in Lung Cancer Screening Eligibility
Revised guidelines perpetuate racial and ethnic disparities in lung cancer screening eligibility
FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion
FDA approves targeted therapy for tumors with KRAS mutations
Preoperative sarcopenia and exercise intolerance predict outcomes following lung cancer surgery
EU Sues More Countries Over Air Pollution, Nature and Water
First Drug That Protects Against Chemo-Induced Myelosuppression
Lung cancer symptoms: What your eyelid says about your risk of lung cancer
Lung cancer – does your face look like this? The unusual signs to watch out for revealed
Breast cancer gene a potential target for childhood liver cancer treatment
